Dysphagia-related quality of life in oculopharyngeal muscular dystrophy: Psychometric properties of the SWAL-QOL instrument

Muscle and Nerve

Volumn 56, Issue 1, 2017, Pages 28-35

  Youssof, Sarah ^a   Romero Clark, Carol ^a   Warner, Teddy ^a   Plowman, Emily ^b  

^a UNIVERSITY OF NEW MEXICO HEALTH SCIENCES CENTER   (United States)

^b UNIVERSITY OF FLORIDA   (United States)

Author keywords

deglutition; disease specific quality of life; muscular dystrophy; reliability; swallowing; validity

Indexed keywords

AGE; AGED; ARTICLE; CLINICAL ASSESSMENT TOOL; CROSS-SECTIONAL STUDY; DISEASE DURATION; DISEASE SEVERITY; DYSPHAGIA; EATING; FATIGUE; FEMALE; HUMAN; INTERNAL CONSISTENCY; INTERPERSONAL COMMUNICATION; MAJOR CLINICAL STUDY; MALE; OCULOPHARYNGEAL MUSCULAR DYSTROPHY; PRIORITY JOURNAL; PROSPECTIVE STUDY; PSYCHOMETRY; QUALITY OF LIFE; SLEEP; SWALLOWING QUALITY OF LIFE INSTRUMENT; TEST RETEST RELIABILITY; VALIDITY; COMPLICATION; DEGLUTITION DISORDERS; MIDDLE AGED; PSYCHOLOGY; REPRODUCIBILITY; RETROSPECTIVE STUDY; SEVERITY OF ILLNESS INDEX; UNITED STATES;

AGED; CROSS-SECTIONAL STUDIES; DEGLUTITION DISORDERS; FEMALE; HUMANS; MALE; MIDDLE AGED; MUSCULAR DYSTROPHY, OCULOPHARYNGEAL; PSYCHOMETRICS; QUALITY OF LIFE; REPRODUCIBILITY OF RESULTS; RETROSPECTIVE STUDIES; SEVERITY OF ILLNESS INDEX; UNITED STATES;

EID: 85012267337     PISSN: 0148639X     EISSN: 10974598     Source Type: Journal    
DOI: 10.1002/mus.25441     Document Type: Article

References (40)

1. Victor M, Hayes R, Adams RD. Oculopharyngeal muscular dystrophy. A familial disease of late life characterized by dysphagia and progressive ptosis of the evelids. N Engl J Med 1962;267:1267–1272.
2. Duranceau CA, Letendre J, Clermont RJ, Levesque HP, Barbeau A. Oropharyngeal dysphagia in patients with oculopharyngeal muscular dystrophy. Can J Surg 1978;21:326–329.
3. Brais B. Oculopharyngeal muscular dystrophy. Handb Clin Neurol 2011;101:181–192.
4. Jones K, Pitceathly RD, Rose MR, McGowan S, Hill M, Badrising UA, et al. Interventions for dysphagia in long-term, progressive muscle disease. Cochrane Database Syst Rev 2016;2:CD004303.
5. Taillefer R, Duranceau AC. Manometric and radionuclide assessment of pharyngeal emptying before and after cricopharyngeal myotomy in patients with oculopharyngeal muscular dystrophy. J Thorac Cardiovasc Surg 1988;95:868–875.
6. Manjaly JG, Vaughan-Shaw PG, Dale OT, Tyler S, Corlett JC, Frost RA. Cricopharyngeal dilatation for the long-term treatment of dysphagia in oculopharyngeal muscular dystrophy. Dysphagia 2012;27:216–220.
7. Perie S, Trollet C, Mouly V, Vanneaux V, Mamchaoui K, Bouazza B, et al. Autologous myoblast transplantation for oculopharyngeal muscular dystrophy: a phase I/IIa clinical study. Mol Ther 2014;22:219–225.
8. Scoggins JF, Patrick DL. The use of patient-reported outcomes instruments in registered clinical trials: evidence from ClinicalTrials.gov. Contemp Clin Trials 2009;30:289–292.
9. McHorney CA, Bricker DE, Kramer AE, Rosenbek JC, Robbins J, Chignell KA, et al. The SWAL-QOL outcomes tool for oropharyngeal dysphagia in adults: I. Conceptual foundation and item development. Dysphagia 2000;15:115–121.
10. Timmerman AA, Speyer R, Heijnen BJ, Klijn-Zwijnenberg IR. Psychometric characteristics of health-related quality-of-life questionnaires in oropharyngeal dysphagia. Dysphagia 2014;29:183–198.
11. McHorney CA, Bricker DE, Robbins J, Kramer AE, Rosenbek JC, Chignell KA. The SWAL-QOL outcomes tool for oropharyngeal dysphagia in adults: II. Item reduction and preliminary scaling. Dysphagia 2000;15:122–133.
12. McHorney CA, Robbins J, Lomax K, Rosenbek JC, Chignell K, Kramer AE, et al. The SWAL-QOL and SWAL-CARE outcomes tool for oropharyngeal dysphagia in adults: III. Documentation of reliability and validity. Dysphagia 2002;17:97–114.
13. Mokkink LB, Terwee CB, Patrick DL, Alonso J, Stratford PW, Knol DL, et al. The COSMIN checklist for assessing the methodological quality of studies on measurement properties of health status measurement instruments: an international Delphi study. Qual Life Res 2010;19:539–549.
14. National Institute of Neurological Disorders and Stroke (NINDS). User Manual for the Quality of Life in Neurological Disorders (Neuro-QoL) Measures, Version 2.0, March 2015. Available at http://www.neuroqol.org/Resources/Resources%20documents/Neuro-QOL_User%20Manual%20v2_24Mar2015.pdf. Accessed April 15, 2016.
15. Youssof S. The relationship between physical symptoms and health-related quality of life in oculopharyngeal muscular dystrophy. Muscle Nerve 2016;53:694–699.
16. Chen YS, Shih HH, Chen TH, Kuo CH, Jong YJ. Prevalence and risk factors for feeding and swallowing difficulties in spinal muscular atrophy types II and III. J Pediatr 2012;160:447–451 e441.
17. Plowman-Prine EK, Sapienza CM, Okun MS, Pollock SL, Jacobson C, Wu SS, et al. The relationship between quality of life and swallowing in Parkinson's disease. Mov Disord 2009;24:1352–1358.
18. McHorney CA, Martin-Harris B, Robbins J, Rosenbek J. Clinical validity of the SWAL-QOL and SWAL-CARE outcome tools with respect to bolus flow measures. Dysphagia 2006;21:141–148.
19. Miller DM, Bethoux F, Victorson D, Nowinski CJ, Buono S, Lai JS, et al. Validating Neuro-QoL short forms and targeted scales with people who have multiple sclerosis. Mult Scler 2016;22:830–841.
20. Nowinski CJ, Siderowf A, Simuni T, Wortman C, Moy C, Cella D. Neuro-QoL health-related quality of life measurement system: validation in Parkinson's disease. Mov Disord 2016;31:725–733.
21. Terwee CB, Bot SD, de Boer MR, van der Windt DA, Knol DL, Dekker J, et al. Quality criteria were proposed for measurement properties of health status questionnaires. J Clin Epidemiol 2007;60:34–42.
22. da Costa Franceschini A, Mourao LF. Dysarthria and dysphagia in Amyotrophic Lateral Sclerosis with spinal onset: a study of quality of life related to swallowing. Neurorehabilitation 2015;36:127–134.
23. Nunnally JB, Bernstein IH. Psychometric theory. New York: McGraw-Hill; 1994.
24. Cook DA, Beckman TJ. Current concepts in validity and reliability for psychometric instruments: theory and application. Am J Med 2006;119:166 e167–e116.
25. Zumbo BD. Validity: foundational issues and statistical methodology. In: Rao CRS, S, editor. Handbook of statistics: psychometrics, Vol 26. The Netherlands: Elsevier Science; 2007. p 45–79.
26. Bentler PM. Comparative fit indexes in structural models. Psychol Bull 1990;107:238–246.
27. Steiger JH. Structural model evaluation and modification: an interval estimation approach. Multivariate Behav Res 1990;25:173–180.
28. Cohen J. A power primer. Psychol Bull 1992;112:155–159.
29. Krause-Bachand J, Koopman W. Living with oculopharyngeal muscular dystrophy: a phenomenological study. Can J Neurosci Nurs 2008;30:35–39.
30. Tabor L, Gaziano J, Watts S, Robison R, Plowman EK. Defining swallowing-related quality of life profiles in individuals with amyotrophic lateral sclerosis. Dysphagia 2016;31:376–382.
31. Ekberg O, Hamdy S, Woisard V, Wuttge-Hannig A, Ortega P. Social and psychological burden of dysphagia: its impact on diagnosis and treatment. Dysphagia 2002;17:139–146.
32. Palmer PM, Neel AT, Sprouls G, Morrison L. Swallow characteristics in patients with oculopharyngeal muscular dystrophy. J Speech Lang Hear Res 2010;53:1567–1578.
33. Duranceau A, Forand MD, Fauteux JP. Surgery in oculopharyngeal muscular dystrophy. Am J Surg 1980;139:33–39.
34. Rinkel RN, Verdonck-de Leeuw IM, Langendijk JA, van Reij EJ, Aaronson NK, Leemans CR. The psychometric and clinical validity of the SWAL-QOL questionnaire in evaluating swallowing problems experienced by patients with oral and oropharyngeal cancer. Oral Oncol 2009;45:e67–e71.
35. Paris G, Martinaud O, Petit A, Cuvelier A, Hannequin D, Roppeneck P, Verin E. Oropharyngeal dysphagia in amyotrophic lateral sclerosis alters quality of life. J Oral Rehabil 2013;40:199–204.
36. van der Sluijs BM, Knoop H, Bleijenberg G, van Engelen BG, Voermans NC. The Dutch patients' perspective on oculopharyngeal muscular dystrophy: a questionnaire study on fatigue, pain and impairments. Neuromuscul Disord 2016;26:221–226.
37. Youssof S, Schrader R, Bear D, Morrison L. Hip flexion weakness is associated with impaired mobility in oculopharyngeal muscular dystrophy: a retrospective study with implications for trial design. Neuromuscul Disord 2015;25:238–246.
38. Blumen SC, Nisipeanu P, Sadeh M, Asherov A, Tome FM, Korczyn AD. Clinical features of oculopharyngeal muscular dystrophy among Bukhara Jews. Neuromuscul Disord 1993;3:575–577.
39. Rinkel RN, Verdonck-de Leeuw IM, de Bree R, Aaronson NK, Leemans CR. Validity of patient-reported swallowing and speech outcomes in relation to objectively measured oral function among patients treated for oral or oropharyngeal cancer. Dysphagia 2015;30:196–204.
40. Lango MN, Egleston B, Fang C, Burtness B, Galloway T, Liu J, et al. Baseline health perceptions, dysphagia, and survival in patients with head and neck cancer. Cancer 2014;120:840–847.